Greykasell Wealth Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$447K Hold
909
0.18% 95
2025
Q4
$527K Buy
909
+25
+3% +$14.1K 0.21% 91
2025
Q3
$429K Buy
884
+15
+2% +$6.98K 0.18% 95
2025
Q2
$352K Sell
869
-315
-27% -$132K 0.17% 98
2025
Q1
$589K Hold
1,184
0.31% 76
2024
Q4
$616K Buy
+1,184
New +$651K 0.34% 78

Other funds holding TMO

Greykasell Wealth Strategies's TMO Position: Q1 2026 in Review

Greykasell Wealth Strategies held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 909 shares worth $447K. The position accounts for 0.18% of the portfolio, ranked #95.

Greykasell Wealth Strategies first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $616K in Q4 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Greykasell Wealth Strategies held 909 shares of Thermo Fisher Scientific worth $447K as of Q1 2026.
  • Greykasell Wealth Strategies left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.18% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #95 holding.
  • Greykasell Wealth Strategies first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Greykasell Wealth Strategies's Thermo Fisher Scientific position peaked at $616K in Q4 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.